Yasmin -- an Oral Contraceptive With a New Progestin
An oral contraceptive (Yasmin - Berlex) containing 3 mg of drospirenone and 30 mcg of ethinyl estradiol is being promoted as having a low incidence of adverse effects....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Yasmin -- an Oral Contraceptive With a New Progestin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1133
Article Code: 1133a
Date: June 24, 2002
Volume: 44
Pages: 55-57
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1133
Article Code: 1133a
Date: June 24, 2002
Volume: 44
Pages: 55-57
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)